Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Associate Scientist, Analytical Development

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Dec 2, 2020

View more

Job Details

Our mission:

Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases.

Intellia is seeking a motivated Analytical Development candidate for a position as Sr. Associate Scientist/Associate Scientist to join our AD team. The individual will develop quantitative cell based assays measuring gene editing in target cells, and cell-based assays measuring the expression and the biological functions of specific genes. The successful candidate will play a leading role in facilitating method transfers, qualifications and validations for multiple clinical programs. He/She will be responsible for analytical development, qualification and operational support for preclinical through late stage clinical development programs for Intellia Therapeutics.

Responsibilities:
    • Develop, optimize and in-house qualification of cell-based bioassay/potency, and flow cytometry assays measuring gene editing, gene expression, gene function within established assay acceptance criteria for gene & cell therapy product characterization, lot release and stability testing
    • Technology Transfer: Act as SME in tech transfer of analytical methods, protocols/procedures and know-how from internal labs to external labs
    • Lab operation: Routine and non-routine analytical testing, coordination with internal/external PD or cGMP manufacturing on sample testing, maintain laboratory equipment, maintain laboratory sample inventory for potency assay, compile and present data to support process development and developmental stability studies
    • Evaluate novel assay technologies and methodologies that could improve existing analytical methods for potency assays
    • Compliant with GxP, keep good lab notebook and experiment records. Authoring and review of SOPs, Development Report, and assist in the preparation of CMC regulatory submissions
    • Assist in maintaining/qualification of critical reagent supply for assigned methods
    • Work collaboratively with Analytical Development and Quality teams to gather and analyze data to achieve method readiness.
    • Work closely with, and support quality control on investigations, OOS, OOTs and release assay trouble shooting


Qualifications:
    • Masters degree with minimum 5+ years of experience; BS with minimum 10+ years of experience in biotech or pharma industry with primary focus on biologics and/or gene and cell therapy
    • Experience in development of cell-based potency assays
    • Experience in tech transfer of assays to CROs
    • Experience of flow cytometry-based assay development
    • Experience in analytical method development, qualification/validation
    • Experience in assay development for cell and gene therapy products highly desirable
    • Excellent communication, technical and organizational skills are required
    • Knowledge of FDA, cGMP, and ICH regulatory requirements in the context of bioassay/potency assay development and qualification is desired
    • Experience and knowledge of QC and GMP regulations
    • Must be able generate SOPs and technical reports with appropriate level of detail, as well as perform bioassay assay trending
    • Prior experience or technical knowledge in molecular assays such as qPCR, ddPCR and NGS is desirable
    • Good understanding of statistical methods/tools for data analysis is strong plus
    • Team player, good interpersonal and organizational skills


#LI-KO1

What Intellia Stands For:

We push boundaries. We are focused on positively disrupting health care treatment of patients with genomic diseases. The values we live by and drivers we look for are:

- One is respect for individuals; our unique qualities and strengths; our own ways to understand, learn and improve. One is our single-minded determination to excel; to succeed together. One is you and us - trusting and counting on every single one of us.

- Explore because we seek new ways to tackle disease. Explore with unbounded minds...free from assumptions, open to ideas. Explore by staying curious, by pushing boundaries, overcoming obstacles. Explore means thinking of new ways.

- Disrupt by thinking courageously...and creating a better future. Disrupt by defying conformity; interrogating the status quo; questioning our momentum. Disrupt with challenging thoughts...with that breed of skepticism that shows you have better solutions.

- Deliver with your focus on the objective and your determination to complete the task. Deliver by advancing relentlessly and by maintaining high standards...even when nobody is watching. Deliver by staying accountable and pulling your weight. Deliver because patients are counting on us to make the promise reality. Get it done.

POSITION: Full-Time, Exempt

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Intellia's web-based application process is managed through Lever. Information submitted through application forms is collected by Lever and subject to Lever's privacy policy .

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert